Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down ...

the active ingredient in Novo Nordisk’s Ozempic and Wegovy. By comparison, about 3.4 million prescriptions for the brand-name counterparts were filled that November, according to the Iqvia ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in ...

A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people with obesity but without diabetes, highlighting its superior effectiveness and cardiometabolic ...

The boss of Ozempic maker Novo Nordisk lost his job yesterday after its share price plunged amid intensifying competition in the multi-billion pound fat jab market. Lars Fruergaard Jorgensen is ...

compare, or demand answers that you're not entitled to, you're not welcome' in her space that she created. She added the caption: 'I'm not on Ozempic. I'm not sick. I didn't get "a new face." ...

In a candid TikTok video posted on May 18, Burke addressed what she called “the elephant in the comments section,” saying, “I’m not on Ozempic ... to speculate, compare, or just demand ...